483 Abraxis Bioscience Oct 2002

483 Abraxis Bioscience Oct 2002

Randall Johnson FDA$119.00 - Available Now

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 24 Oct 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Oct 2002
  • Location: Phoenix, United States
  • FEI: 2025487
Add To Cart